Becky Winslow, PharmD & Pharmacy Student Kaitlyn Marshall re-launch the PGX for Pharmacists. 

23andMe announced in August of 2020 that it has received a 510(k) clearance from the FDA that allows its direct-to-consumer personal pharmacogenetics report to guide use of two treatments without the need for confirmatory testing.

This action updates a De Novo approval granted to the consumer genomics company in late 2018. That decision allowed 23andMe to market a test for one of 33 variants across multiple genes that could impact metabolization of certain medication, but came with a handful of "special controls." Among these were labeling requirements that warned consumers not to use the product for any medication decisions without additional independent testing.

Guests: 
Becky Winslow, BS, PharmD - Medical Affairs 

Dr. Becky Winslow, earned both her Bachelors of Science in Biology and her doctorate in clinical pharmacy from Campbell University. She earned her Test2Learn(TM) Community-Based Pharmacogenomics Certificate, as well as, her  "Train the Trainer"  certification through NACDS and The University of Pittsburgh School of Pharmacy. 

Dr. Winslow brings over 20 years experience building clinical pharmacy programs, as well as, directing pharmacy business operations in the community setting to inGENEiosu RX. She has patient facing clinical experience as a pharmacist in retail, hospital, public health, and long term care pharmacies. Dr. Winslow founded and has owned her general pharmacy consulting business for over 20 years. In the last 6 years, she has specialized in pharmacogenomics consulting. 

Dr. Winslow's professional associations include being a member of the Clinical Pharmacogenetics Implementation Consortium and The Get the Medications Right Institute.

Now recognized as a community pharmacogenomics subject matter expert, Dr. Winslow is sought after to create and present original pharmacogenomics content and to consult for pharmacogenomics industry vendors and the clients they serve.
Kaitlyn Marshall - PharmD Candidate 2021

Becky Winslow, PharmD &amp; Pharmacy Student Kaitlyn Marshall re-launch the PGX for Pharmacists.&nbsp;
23andMe announced in August of 2020 that it has received a 510(k) clearance from the FDA that allows its direct-to-consumer personal pharmacogenetics report to guide use of two treatments without the need for confirmatory testing.
This action updates&nbsp;<a href="https://www.mobihealthnews.com/content/fda-grants-23andme%E2%80%99s-consumer-genetic-variant-test-de-novo-approval-some-caveats">a De Novo approval</a>&nbsp;granted to the consumer genomics company in late 2018. That decision allowed 23andMe to market a test for one of 33 variants across multiple genes that could impact metabolization of certain medication, but came with a handful of "special controls." Among these were labeling requirements that warned consumers not to use the product for any medication decisions without additional independent testing.
Guests:&nbsp;
<ul>
<li><a href="https://www.linkedin.com/in/beckywinslow/">Becky Winslow, BS, PharmD - Medical Affairs&nbsp;</a></li>
</ul>
Dr. Becky Winslow, earned both her Bachelors of Science in Biology and her doctorate in clinical pharmacy from Campbell University. She earned her Test2Learn(TM) Community-Based Pharmacogenomics Certificate, as well as, her&nbsp; "Train the Trainer"&nbsp; certification through NACDS and The University of Pittsburgh School of Pharmacy.&nbsp;
Dr. Winslow brings over 20 years experience building clinical pharmacy programs, as well as, directing pharmacy business operations in the community setting to inGENEiosu RX. She has patient facing clinical experience as a pharmacist in retail, hospital, public health, and long term care pharmacies. Dr. Winslow founded and has owned her general pharmacy consulting business for over 20 years. In the last 6 years, she has specialized in pharmacogenomics consulting.&nbsp;
Dr. Winslow's professional associations include being a member of the Clinical Pharmacogenetics Implementation Consortium and The Get the Medications Right Institute.
Now recognized as a community pharmacogenomics subject matter expert, Dr. Winslow is sought after to create and present original pharmacogenomics content and to consult for pharmacogenomics industry vendors and the clients they serve.
<ul>
<li><a href="https://www.linkedin.com/in/kaitlyn-marshall-bba757187/">Kaitlyn Marshall - PharmD Candidate 2021</a></li>
</ul>

In March of 2009, Todd S. Eury, launched the Pharmacy Podcast Show. Over the years, the Pharmacy Podcast has accumulated over 75,000+ listeners and subscribers and is the most popular and downloaded podcast about the Pharmacy Industry.

The Pharmacy Podcast Show transformed into the Pharmacy Podcast Network (PPN) in 2014 and will continue to collect the thought leading interviews with some of the most brilliant minds in Pharmacy with over 30 co-hosts. The PPN is a Digital Health Publication and Content Developing partner to the Pharmaceutical industry focusing on Specialty medications, pharmacy business supportive technologies, and industry trends.

The PPN is the world's largest network of podcasts dedicated to the pharmacy professional and industry insiders leading with our hosts interviewing dynamic people in the pharmacy industry making a difference for our profession, customers, and patients.

The definition of “Innovation” is: A new method, idea, product, or process. Processing, implementing, operating, or designing beyond the status-quo. Pharmacists are the HUB of Healthcare & the PPN is the Pharmacist's biggest fan. 

In March of 2009, Todd S. Eury, launched the Pharmacy Podcast Show. Over the years, the Pharmacy Podcast has accumulated over 75,000+ listeners and subscribers and is the most popular and downloaded podcast about the Pharmacy Industry.
The Pharmacy Podcast Show transformed into the Pharmacy Podcast Network (PPN) in 2014 and will continue to collect the thought leading interviews with some of the most brilliant minds in Pharmacy with over 30 co-hosts. The PPN is a Digital Health Publication and Content Developing partner to the Pharmaceutical industry focusing on Specialty medications, pharmacy business supportive technologies, and industry trends.
The PPN is the world's largest network of podcasts dedicated to the pharmacy professional and industry insiders leading with our hosts interviewing dynamic people in the pharmacy industry making a difference for our profession, customers, and patients.
The definition of &ldquo;Innovation&rdquo; is: A new method, idea, product, or process. Processing, implementing, operating, or designing beyond the status-quo. Pharmacists are the HUB of Healthcare &amp; the PPN is the Pharmacist's biggest fan.&nbsp;

Pharmacy Podcast Network

This podcast is all about the Pharmacist leveraging the power of Pharmacogenomics. 

PGX for Pharmacists is a member of the Pharmacy Podcast Network. 

Pharmacogenomics is the study of the role of the genome in drug response.

Its name (pharmaco- + genomics) reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics (drug absorption, distribution, metabolism, and elimination) and pharmacodynamics (effects mediated through a drug's biological targets).

This podcast is all about the Pharmacist leveraging the power of Pharmacogenomics.&nbsp;
PGX for Pharmacists is a member of the Pharmacy Podcast Network.&nbsp;
Pharmacogenomics is the study of the role of the genome in drug response.
Its name (pharmaco- + genomics) reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics (drug absorption, distribution, metabolism, and elimination) and pharmacodynamics (effects mediated through a drug's biological targets).

PGX for Pharmacists

The Pharmacy Podcast Network is ranked as the number one podcast in healthcare dedicated to the Business of Pharmacy and TOP 25 Podcasts in U.S. Business News. The most influential voices in the pharmacy industry are published on the Pharmacy Podcast Network (PPN). The PPN is the leading audio authority of the pharmaceutical & pharmacy industry with more than 30 hosts, 1,200+ episodes, supporting more than 25+ pharmacy industry associations, with more than 80,000 listeners world wide. 

The PPN is an Audio Branding & Public Relations Communications company dedicated to the Pharmaceutical industry focusing on Community, Long-term care, Health System, Specialty, pharmacy business supportive technologies, and industry trends. 

Pharmacy Podcast™ is a registered trademark

The Pharmacy Podcast Network is ranked as the number one podcast in healthcare dedicated to the Business of Pharmacy and TOP 25 Podcasts in U.S. Business News. The most influential voices in the pharmacy industry are published on the Pharmacy Podcast Network (PPN). The PPN is the leading audio authority of the pharmaceutical &amp; pharmacy industry with more than 30 hosts, 1,200+ episodes, supporting more than 25+ pharmacy industry associations, with more than 80,000 listeners world wide.&nbsp;
The PPN is an Audio Branding &amp; Public Relations Communications company dedicated to the Pharmaceutical industry focusing on Community, Long-term care, Health System, Specialty, pharmacy business supportive technologies, and industry trends.&nbsp;
Pharmacy Podcast&trade; is a registered trademark

The Next Phase of Pharmacogenomics & the Pharmacist | PGX for Pharmacists

Each day, more than 130 people die from opioid overdoses.

Opioids are a class of drugs that include prescription pain relievers like oxycodone. They also include illegal drugs like heroin. In 2019, 1.6 million Americans had an opioid addiction. This is also known as opioid use disorder. Yet effective medications—like buprenorphine, methadone, and naltrexone—are prescribed to only a fraction of people with opioid use disorder. Patients often receive such medications in an opioid treatment program. Methadone, for example, can only be given in a certified treatment program. Primary care physicians can apply for a waiver to prescribe buprenorphine. However, less than 10% of U.S. primary care providers have a buprenorphine waiver. Given the limited number of patients that each physician can treat, involving pharmacists in opioid treatment may improve access.

The Doctor Patient Forum’s Mission Statement is to advocate, educate, and defend the rights of patients, to protect all providers (including prescribers and pharmacists) who tirelessly work to treat their patients, and to bring awareness to the general public regarding restrictions upon medical providers. We are fighting for a return to individualized patient care instead of using guidelines and laws based on little evidence using arbitrary thresholds. Contrary to what has been said, we are not “industry funded.” We haven’t taken any money from pharma. We are not being paid to promote opioids. We are simply chronic pain and illness patients who are fighting as hard as we can to effect change in this broken system where the patient’s voice is non-existent.

For part 4 of the series, we're honored to have Ms. Bev Schechtman. Ms. Schectman is one of the founding members of Don’t Punish Pain Rally and is the VP of The Doctor Patient Forum. She grew up in northern New Jersey, and has lived in the Raleigh area in North Carolina since 2009. Bev has been married to Randy for 18 years, and has two teenage daughters, Emma, 17, and Livvy,13. She also has a 3-year-old Aussidoodle, Griffin.

Bev has been living with Crohn’s Disease and Psoriatic Arthritis for over two decades. She first contacted Claudia Merandi after being denied opioid medication while hospitalized for kidney stones in 2017.She was denied due to being a survivor of childhood sexual abuse. Bev is a passionate advocate for people with chronic pain and illness as well as those who have PTSD/ survived sexual assault/abuse. Bev has her B.A. in Psychology and hopes to get her M.S.W. in the near future. Bev is a voracious reader and researcher. She is passionate about understanding why pain patients are being mistreated so she can educate other patients and empower them to fight back. Bev hopes her advocacy work brings awareness to the anti-opioid zealots who are profiting off of punishing pain patients while pretending to care about those with addiction. She also believes strongly in Harm Reduction efforts.

Each day, more than 130 people die from opioid overdoses.
Opioids are a class of drugs that include prescription pain relievers like oxycodone. They also include illegal drugs like heroin. In 2019, 1.6 million Americans had an opioid addiction. This is also known as opioid use disorder. Yet effective medications&mdash;like buprenorphine, methadone, and&nbsp;<a href="https://en.wikipedia.org/wiki/Naltrexone">naltrexone</a>&mdash;are prescribed to only a fraction of people with opioid use disorder. Patients often receive such medications in an opioid treatment program.&nbsp;<a href="https://en.wikipedia.org/wiki/Methadone">Methadone</a>, for example, can only be given in a certified treatment program. Primary care physicians can apply for a waiver to prescribe&nbsp;<a href="https://medlineplus.gov/druginfo/meds/a605002.html">buprenorphine</a>. However, less than 10% of U.S. primary care providers have a buprenorphine waiver. Given the limited number of patients that each physician can treat, involving pharmacists in opioid treatment may improve access.
The Doctor Patient Forum&rsquo;s Mission Statement is to advocate, educate, and defend the rights of patients, to protect all providers (including prescribers and pharmacists) who tirelessly work to treat their patients, and to bring awareness to the general public regarding restrictions upon medical providers. We are fighting for a return to individualized patient care instead of using guidelines and laws based on little evidence using arbitrary thresholds. Contrary to what has been said, we are not &ldquo;industry funded.&rdquo; We haven&rsquo;t taken any money from pharma. We are not being paid to promote opioids. We are simply chronic pain and illness patients who are fighting as hard as we can to effect change in this broken system where the patient&rsquo;s voice is non-existent.
For part 4 of the series, we're honored to have Ms. Bev Schechtman. Ms. Schectman is one of the founding members of Don&rsquo;t Punish Pain Rally and is the VP of The Doctor Patient Forum. She grew up in northern New Jersey, and has lived in the Raleigh area in North Carolina since 2009. Bev has been married to Randy for 18 years, and has two teenage daughters, Emma, 17, and Livvy,13. She also has a 3-year-old Aussidoodle, Griffin.
Bev has been living with Crohn&rsquo;s Disease and Psoriatic Arthritis for over two decades. She first contacted Claudia Merandi after being denied opioid medication while hospitalized for kidney stones in 2017.She was denied due to being a survivor of childhood sexual abuse. Bev is a passionate advocate for people with chronic pain and illness as well as those who have PTSD/ survived sexual assault/abuse. Bev has her B.A. in Psychology and hopes to get her M.S.W. in the near future. Bev is a voracious reader and researcher. She is passionate about understanding why pain patients are being mistreated so she can educate other patients and empower them to fight back. Bev hopes her advocacy work brings awareness to the anti-opioid zealots who are profiting off of punishing pain patients while pretending to care about those with addiction. She also believes strongly in Harm Reduction efforts.

Where's the Patient's Voice in Evidence-based Treatment & Research? | Pharmacist and Physician Opioid Collaborative

Pharmacists Answering the call | Pharmacy Podcast Nation

Ila M. Saunders, PharmD, BCOP, co-founder and leadership team member of the #PharmGradWishList interviews Ja’Miera Stuart, PharmD, #PGWL sponsee and winner of a large item crowdfunding campaign to support moving and relocation expenses to begin her PGY1 pharmacy residency.

Dr. Stuart has been interested in a career in pharmacy since high school when she began pre-pharmacy coursework. As a graduate of Florida A&M University, Dr. Stuart truly embraced the role of the pharmacist as a healthcare practitioner and ambassador. During her involvement in Student National Pharmaceutical Association, Dr. Stuart rallied and amplified the voices of underrepresented minorities. Now, Dr. Stuart began her career and continued her education as a pharmacy resident at Howard University Hospital, serving a pivotal patient population in the DC metro area.

Dr. Stuart is grateful for the generous outpouring of support from the pharmacy community who have and continue to help her achieve her goals and aspirations. She remains passionate about supporting opportunities, like those she has received, to continue diversifying pharmacy and healthcare.

To support other aspiring pharmacists, like Dr. Stuart, please follow more of her story on her instagram @morph_rx and you can find more information at pharmgradwishlist.org! 

Ila M. Saunders, PharmD, BCOP, co-founder and leadership team member of the #PharmGradWishList interviews&nbsp;Ja&rsquo;Miera Stuart, PharmD, #PGWL sponsee and winner of a large item crowdfunding campaign to support moving and relocation expenses to begin her PGY1 pharmacy residency.
Dr. Stuart has been interested in a career in pharmacy since high school when she began pre-pharmacy coursework. As a graduate of Florida A&amp;M University, Dr. Stuart truly embraced the role of the pharmacist as a healthcare practitioner and ambassador. During her involvement in Student National Pharmaceutical Association, Dr. Stuart rallied and amplified the voices of underrepresented minorities. Now, Dr. Stuart began her career and continued her education as a pharmacy resident at Howard University Hospital, serving a pivotal patient population in the DC metro area.
Dr. Stuart is grateful for the generous outpouring of support from the pharmacy community who have and continue to help her achieve her goals and aspirations. She remains passionate about supporting opportunities, like those she has received, to continue diversifying pharmacy and healthcare.
To support other aspiring pharmacists, like Dr. Stuart, please follow more of her story on her instagram @morph_rx and you can find more information at&nbsp;<a href="https://www.listennotes.com/podcasts/pharmacy-podcast/jamiera-stuart-brighter-WaVAb4oIEGp/pharmgradwishlist.org">pharmgradwishlist.org</a>!&nbsp;

The Next Phase of Pharmacogenomics & the Pharmacist | PGX for Pharmacists

In 2 playlist(s)

Pharmacy Podcast Network

Social links

Follow podcast

Recent clips